The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-{[(5-Chloro-3-methyl-1-benzothien-2-yl)sulfonyl]amino}benzoic acid ID: ALA3728731
Cas Number: 1365719-41-0
PubChem CID: 56941306
Max Phase: Preclinical
Molecular Formula: C16H12ClNO4S2
Molecular Weight: 381.86
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1c(S(=O)(=O)Nc2cccc(C(=O)O)c2)sc2ccc(Cl)cc12
Standard InChI: InChI=1S/C16H12ClNO4S2/c1-9-13-8-11(17)5-6-14(13)23-16(9)24(21,22)18-12-4-2-3-10(7-12)15(19)20/h2-8,18H,1H3,(H,19,20)
Standard InChI Key: NFLZAWLLXDSRBZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
-0.4916 -3.8582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3114 -2.9665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8032 -3.1233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4133 -1.7530 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3383 1.3500 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5524 -4.4208 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
3.7524 -4.4204 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.1529 -5.4597 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.8028 -5.7210 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5532 -7.0208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8059 -8.3214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5586 -9.6189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0586 -9.6159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8059 -8.3153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0533 -7.0178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3067 -8.3091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9031 -7.2678 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.9107 -9.3461 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
8 10 1 0
10 11 2 0
11 2 1 0
11 5 1 0
3 12 1 0
12 13 2 0
12 14 2 0
12 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
20 22 1 0
22 23 2 0
22 24 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 381.86Molecular Weight (Monoisotopic): 380.9896AlogP: 4.36#Rotatable Bonds: 4Polar Surface Area: 83.47Molecular Species: ACIDHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.96CX Basic pKa: ┄CX LogP: 4.28CX LogD: 0.40Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.70Np Likeness Score: -1.51
References 1. (2012) New compounds, 2. (2016) Sulfonamide compounds, 3. Wang Y, Qu C, Liu T, Wang C.. (2020) PFKFB3 inhibitors as potential anticancer agents: Mechanisms of action, current developments, and structure-activity relationships., 203 [PMID:32679452 ] [10.1016/j.ejmech.2020.112612 ]